Cresco Labs Inc (CL)
Canadian Securities Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 0.820 |
|---|---|
| 52-week range | 0.810 – 3.120 |
| Return, 1 month / 3 months | −19.6% / −21.9% |
| Return, 1 year / 3 years | −55.9% / −64.3% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 127.0% |
| Worst drawdown (1 year) | -69.9% |
| Average daily value traded | 0.08M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cresco Labs is a cannabis company based in Chicago that cultivates, processes and sells cannabis products for medical and recreational customers in the United States. Its range includes dried flower, vape products, concentrates and edible products, sold under its own consumer brands. The company also runs retail dispensaries in the states where it operates, serving adult-use and medical patients through its own stores and through wholesale relationships with other licensed retailers.
On this site Cresco Labs Inc appears as a stock on the Canadian Securities Exchange (Canada), code CL, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cresco Labs Inc (CL) trades on the Canadian Securities Exchange in Canada. It last closed at CAD 0.820 on 19 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 161 of 268 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 55.9% and over the last three months it fell 21.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Canadian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -33.8% | ||
| From 52-week high | -69.9% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.9% | ||
| 6-month return | -34.9% | ||
| 12-month return, skipping the last month | -45.2% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 127.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -69.9% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 0.08M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −10.9% |
|---|---|
| 1 month | −19.6% |
| 3 months | −21.9% |
| 6 months | −34.9% |
| 1 year | −55.9% |
| 3 years | −64.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.017 / 1.238 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.045 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Canadian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.